By John Pappas

Whether it is triggered by a whistleblower’s tip related to Foreign Corrupt Practices Act compliance, suspicions of deceptive sales and marketing practices, or hints of trade secret or other intellectual property theft, a regulatory investigation is nothing any pharmaceutical or medical device company wants. It allows the investigating agency to open a sweeping investigation that can encompass a company’s entire document repository, draining an incredible amount of the company’s time and resources.

Read Full Article (PDF)


Phone: 303.824.0900 | Toll Free: 877.557.4273
Fax: 303.293.9073
Privacy Policy | Privacy Shield

About Catalyst

Catalyst designs, builds, hosts and supports the world’s fastest and most powerful e-discovery platform. For 20 years, Catalyst has helped global corporations reduce the total cost of discovery and take control of complex, large-scale discovery and regulatory compliance.

Copyright © 2019 Catalyst Repository Systems. All Rights Reserved.